Viatris/VTRS

$11.23

-0.18%
-
1D1W1MYTD1YMAX

About Viatris

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as the Company’s ARV franchise. Its portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas, including key brands and generics, including complex products. It operates around 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.

Ticker

VTRS

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Scott Smith

Employees

38,000

Headquarters

Canonsburg, United States

Viatris Metrics

BasicAdvanced
$13.36B
Market cap
265.77
P/E ratio
$0.04
EPS
1.14
Beta
$0.48
Dividend rate
4.27%
Dividend yield
$13.36B
1.13574
$13.62
$8.74
8.96M
$0.48
1.668
1.222
79.092
88.545
1,079.71%
17.423
2.79%
0.11%
0.26%
0.13%
265.769
0.866
0.66
7.637
4.27%
4.27%
-5.14%
-97.52%
8.9%

What the Analysts think about Viatris

Analyst Ratings

Majority rating from 10 analysts.
Hold

Price Targets

Average projection from 7 analysts.
39.89% upside
High $35.00
Low $11.00
$11.23
Current price
$15.71
Average price target

Viatris Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-19.95% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$3.84B
-2.65%
Net income
$-765.6M
-330.88%
Profit margin
-19.95%
-337.22%

Viatris Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 4.12%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.77
$0.75
$0.79
$0.62
-
Expected
$0.69
$0.71
$0.74
$0.65
$0.67
Surprise
12.16%
5.59%
6.72%
-4.12%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Viatris stock?

Viatris (VTRS) has a market cap of $13.36B as of April 23, 2024.

What is the P/E ratio for Viatris stock?

The price to earnings (P/E) ratio for Viatris (VTRS) stock is 265.77 as of April 23, 2024.

Does Viatris stock pay dividends?

Yes, the Viatris (VTRS) stock pays dividends to shareholders. As of April 23, 2024, the dividend rate is $0.48 and the yield is 4.27%. Viatris has a payout ratio of 1079.71% on a trailing twelve-month basis.

When is the next Viatris dividend payment date?

The next Viatris (VTRS) dividend payment date is unconfirmed.

What is the beta indicator for Viatris?

Viatris (VTRS) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Viatris stock price target?

The target price for Viatris (VTRS) stock is $15.71, which is 38.29% above the current price of $11.36. This is an average based on projections from 7 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Viatris stock

Buy or sell Viatris stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing